Yahoo! Finance: Biotechnology Industry News: U.S. FDA approves Actelion's lung disease drug Opsumit

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

Subscribe to Bloomberg Businessweek Get Bloomberg Businessweek for 84% off what others pay on the newsstand - that's like getting 38 complimentary issues! Sign up today. From our sponsors

U.S. FDA approves Actelion's lung disease drug Opsumit Oct 18th 2013, 22:31 [Reuters] - Actelion Ltd has won U.S. approval for its drug Opsumit, a successor to its pulmonary arterial hypertension drug Tracleer, which loses patent protection in 2015. Pulmonary arterial hypertension, or PAH, ...

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions